{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:05:23Z","timestamp":1787241923514,"version":"build-2736575974"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12272-020-01297-0","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T11:02:59Z","timestamp":1606474979000},"page":"1276-1296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Therapeutic effects of histone deacetylase inhibitors on heart disease"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7349-9880","authenticated-orcid":false,"given":"Pusoon","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"1297_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1152\/physrev.00032.2006","volume":"87","author":"P Ahuja","year":"2007","unstructured":"Ahuja P, Sdek P, MacLellan WR (2007) Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87:521\u2013544. https:\/\/doi.org\/10.1152\/physrev.00032.2006","journal-title":"Physiol Rev"},{"key":"1297_CR2","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","volume":"92","author":"H Akazawa","year":"2003","unstructured":"Akazawa H, Komuro I (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92:1079\u20131088. https:\/\/doi.org\/10.1161\/01.RES.0000072977.86706.23","journal-title":"Circ Res"},{"key":"1297_CR3","doi-asserted-by":"publisher","first-page":"e0139858","DOI":"10.1371\/journal.pone.0139858","volume":"10","author":"A Angelini","year":"2015","unstructured":"Angelini A, Li Z, Mericskay M, Decaux JF (2015) Regulation of connective tissue growth factor and cardiac fibrosis by an SRF\/MicroRNA-133a axis. PLoS ONE 10:e0139858. https:\/\/doi.org\/10.1371\/journal.pone.0139858","journal-title":"PLoS ONE"},{"key":"1297_CR4","doi-asserted-by":"publisher","first-page":"28930","DOI":"10.1074\/jbc.M303113200","volume":"278","author":"CL Antos","year":"2003","unstructured":"Antos CL, McKinsey TA, Dreitz M, Hollingsworth LM, Zhang CL, Schreiber K, Rindt H, Gorczynski RJ, Olson EN (2003) Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278:28930\u201328937. https:\/\/doi.org\/10.1074\/jbc.M303113200","journal-title":"J Biol Chem"},{"key":"1297_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yjmcc.2014.03.005","volume":"72","author":"SE Aune","year":"2014","unstructured":"Aune SE, Herr DJ, Mani SK, Menick DR (2014) Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. J Mol Cell Cardiol 72:138\u2013145. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.03.005","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/VHRM.S166157","volume":"15","author":"S Aydin","year":"2019","unstructured":"Aydin S, Ugur K, Aydin S, Sahin \u0130, Yardim M (2019) Biomarkers in acute myocardial infarction: current perspectives. Vasc Health Risk Manag 15:1\u201310. https:\/\/doi.org\/10.2147\/VHRM.S166157","journal-title":"Vasc Health Risk Manag"},{"key":"1297_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/ajh\/hpx067","volume":"30","author":"CN Bang","year":"2017","unstructured":"Bang CN, Soliman EZ, Simpson LM, Davis BR, Devereux RB, Okin PM (2017) Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study. Am J Hypertens 30:914\u2013922. https:\/\/doi.org\/10.1093\/ajh\/hpx067","journal-title":"Am J Hypertens"},{"key":"1297_CR8","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/ATVBAHA.114.303848","volume":"34","author":"SA Barman","year":"2014","unstructured":"Barman SA, Chen F, Su Y, Dimitropoulou C, Wang Y, Catravas JD, Han W, Laszlo Orfi L, Szantai-Kis C, Keri G, Szabadkai I, Barabutis N, Rafikova O, Rafikov R, Black SM, Jonigk D, Giannis A, Asmis R, Stepp DW, Ramesh G, Fulton DJR (2014) NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling. Arterioscler Thromb Vasc Biol 34:1704\u20131715. https:\/\/doi.org\/10.1161\/ATVBAHA.114.303848","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1297_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrm3629","volume":"14","author":"C Bertoli","year":"2013","unstructured":"Bertoli C, Skotheim JM, de Bruin RAM (2013) Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol 14:518\u2013528. https:\/\/doi.org\/10.1038\/nrm3629","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1297_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1139\/o01-032","volume":"79","author":"NR Bertos","year":"2001","unstructured":"Bertos NR, Wang AH, Yang XJ (2001) Class II histone deacetylases: structure, function, and regulation. Biochem Cell Biol 79:243\u2013252","journal-title":"Biochem Cell Biol"},{"key":"1297_CR11","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","volume":"45","author":"P Bertrand","year":"2010","unstructured":"Bertrand P (2010) Inside HDAC with HDAC inhibitors. Eur J Med Chem 45:2095\u20132116. https:\/\/doi.org\/10.1016\/j.ejmech.2010.02.030","journal-title":"Eur J Med Chem"},{"issue":"2","key":"1297_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","volume":"14","author":"A Besson","year":"2008","unstructured":"Besson A, Dowdy SF, Roberts JM (2008) CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14(2):159\u2013169. https:\/\/doi.org\/10.1016\/j.devcel.2008.01.013","journal-title":"Dev Cell"},{"key":"1297_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/pr.2017.126","volume":"82","author":"WW Blakeslee","year":"2017","unstructured":"Blakeslee WW, Demos-Davies KM, Lemon DD, Lutter KM, Cavasin MA, Payne S, Nunley K, Long CS, McKinsey TA, Miyamoto SD (2017) Histone deacetylase adaptation in single ventricle heart disease and a young animal model of right ventricular hypertrophy. Pediatr Res 82:642\u2013649. https:\/\/doi.org\/10.1038\/pr.2017.126","journal-title":"Pediatr Res"},{"key":"1297_CR14","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/ijms20081873","volume":"20","author":"L Bocchi","year":"2019","unstructured":"Bocchi L, Motta BM, Savi M, Vilella R, Meraviglia V, Rizzi F, Galati S, Buschini A, Lazzaretti M, Pramstaller PP, Rossini A, Stilli D (2019) The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) restores cardiomyocyte contractility in a rat model of early diabetes. Int J Mol Sci 20:1873. https:\/\/doi.org\/10.3390\/ijms20081873","journal-title":"Int J Mol Sci"},{"key":"1297_CR15","doi-asserted-by":"publisher","first-page":"e22217","DOI":"10.1371\/journal.pone.0022217","volume":"6","author":"C Bolte","year":"2011","unstructured":"Bolte C, Zhang Y, Wang IC, Kalin TV, Molkentin JD, Kalinichenko VV (2011) Expression of Foxm1 transcription factor in cardiomyocytes is required for myocardial development. PLoS ONE 6:e22217. https:\/\/doi.org\/10.1371\/journal.pone.0022217","journal-title":"PLoS ONE"},{"key":"1297_CR16","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1172\/JCI17295","volume":"111","author":"JC Braz","year":"2003","unstructured":"Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD (2003) Targeted lihibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J Clin Invest 111:1475\u20131486. https:\/\/doi.org\/10.1172\/JCI17295","journal-title":"J Clin Invest"},{"key":"1297_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0008-6363(98)00125-4","volume":"39","author":"G Brooks","year":"1998","unstructured":"Brooks G, Poolman RA, Li JM (1998) Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors. Cardiovasc Res 39:301\u2013311. https:\/\/doi.org\/10.1016\/s0008-6363(98)00125-4","journal-title":"Cardiovasc Res"},{"key":"1297_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/s0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857\u2013868. https:\/\/doi.org\/10.1016\/s0092-8674(00)80595-4","journal-title":"Cell"},{"key":"1297_CR19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/01.res.0000038488.38975.1a","volume":"91","author":"OF Bueno","year":"2002","unstructured":"Bueno OF, Molkentin JD (2002) Involvement of extracellular signal-regulated kinases 1\/2 in cardiac hypertrophy and cell death. Circ Res 91:776\u2013781. https:\/\/doi.org\/10.1161\/01.res.0000038488.38975.1a","journal-title":"Circ Res"},{"key":"1297_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","volume":"128","author":"JS Burchfield","year":"2013","unstructured":"Burchfield JS, Xie M, Hill JA (2013) Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation 128:388\u2013400. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001878","journal-title":"Circulation"},{"key":"1297_CR21","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1073\/pnas.1015081108","volume":"108","author":"DJ Cao","year":"2011","unstructured":"Cao DJ, Wang ZV, Battiprolu PK, Jiang N, Morales CR, Kong Y, Rothermel BA, Gillette TG, Hill JA (2011) Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci USA 108:4123\u20134128. https:\/\/doi.org\/10.1073\/pnas.1015081108","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.110.154567","volume":"56","author":"JP Cardinale","year":"2010","unstructured":"Cardinale JP, Sriramula S, Pariaut R, Guggilam A, Mariappan N, Elks CM, Francis J (2010) HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 56:437\u2013444. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.154567","journal-title":"Hypertension"},{"key":"1297_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Car\u00e8","year":"2007","unstructured":"Car\u00e8 A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MVG, H\u00f8ydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613\u2013618. https:\/\/doi.org\/10.1038\/nm1582","journal-title":"Nat Med"},{"key":"1297_CR24","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Muntner P, Bosworth HB, Whelton PK (2018) Prevention and control of hypertension: JACC health promotion series. J Am Coll Cardiol 72:1278\u20131293. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.008","journal-title":"J Am Coll Cardiol"},{"key":"1297_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cvr\/cvp203","volume":"84","author":"SM Chaldoupi","year":"2009","unstructured":"Chaldoupi SM, Loh P, Hauer RNW, de Bakker JMT, van Rijen HVM (2009) The role of connexin40 in atrial fibrillation. Cardiovasc Res 84:15\u201323. https:\/\/doi.org\/10.1093\/cvr\/cvp203","journal-title":"Cardiovasc Res"},{"key":"1297_CR26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA (2003) Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17:590\u2013603. https:\/\/doi.org\/10.1038\/sj.leu.2402824","journal-title":"Leukemia"},{"key":"1297_CR27","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","volume":"24","author":"S Chang","year":"2004","unstructured":"Chang S, McKinsey TA, Zhang CL, Richardson JA, Hill JA, Olson EN (2004) Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24:8467\u20138476. https:\/\/doi.org\/10.1128\/MCB.24.19.8467-8476.2004","journal-title":"Mol Cell Biol"},{"key":"1297_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.trsl.2018.06.002","volume":"200","author":"CJ Chang","year":"2018","unstructured":"Chang CJ, Li SJ, Chen YC, Huang SY, Chen SA, Chen YJ (2018) Histone deacetylase inhibition attenuates atrial arrhythmogenesis in sterile pericarditis. Transl Res 200:54\u201364. https:\/\/doi.org\/10.1016\/j.trsl.2018.06.002","journal-title":"Transl Res"},{"key":"1297_CR29","doi-asserted-by":"publisher","first-page":"a026104","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J (2016) The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med 6:a026104. https:\/\/doi.org\/10.1101\/cshperspect.a026104","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1297_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/s0092-8674(02)00932-7","volume":"110","author":"F Chen","year":"2002","unstructured":"Chen F, Kook H, Milewski R, Gitler AD, Lu MM, Li J, Nazarian R, Schnepp R, Jen K, Biben C, Runke G, Mackay JP, Novotny J, Schwartz RJ, Harvey RP, Mullins MC, Epstein JA (2002) Hop is an unusual homeobox gene that modulates cardiac development. Cell 110:713\u2013723. https:\/\/doi.org\/10.1016\/s0092-8674(02)00932-7","journal-title":"Cell"},{"key":"1297_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-015-0262-8","volume":"14","author":"Y Chen","year":"2015","unstructured":"Chen Y, Du J, Zhao YT, Zhang L, Lv G, Zhuang S, Qin G, Zhao TC (2015) Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc Diabetol 14:99. https:\/\/doi.org\/10.1186\/s12933-015-0262-8","journal-title":"Cardiovasc Diabetol"},{"key":"1297_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3892\/ijo.2017.4094","volume":"51","author":"Y Chen","year":"2017","unstructured":"Chen Y, Liu Y, Ni H, Ding C, Zhang X, Zhang Z (2017) FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis. Int J Oncol 51:1045\u20131054. https:\/\/doi.org\/10.3892\/ijo.2017.4094","journal-title":"Int J Oncol"},{"key":"1297_CR33","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1253\/circj.cj-09-0580","volume":"74","author":"YK Cho","year":"2010","unstructured":"Cho YK, Eom GH, Kee HJ, Kim HS, Choi WY, Nam KI, Ma JS, Kook H (2010) Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats. Circ J 74:760\u2013770. https:\/\/doi.org\/10.1253\/circj.cj-09-0580","journal-title":"Circ J"},{"key":"1297_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12272-017-0998-7","volume":"41","author":"P Chun","year":"2018","unstructured":"Chun P (2018) Therapeutic effects of histone deacetylase inhibitors on kidney disease. Arch Pharm Res 41:162\u2013183. https:\/\/doi.org\/10.1007\/s12272-017-0998-7","journal-title":"Arch Pharm Res"},{"key":"1297_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc1819","volume":"6","author":"M Cully","year":"2006","unstructured":"Cully M, You H, Levine AJ, Mak TW (2006) Beyond pten mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6:184\u2013192. https:\/\/doi.org\/10.1038\/nrc1819","journal-title":"Nat Rev Cancer"},{"key":"1297_CR36","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/BJ20021321","volume":"370","author":"AJM de Ruijter","year":"2003","unstructured":"de Ruijter AJM, van Gennip AH, Caron HN, Kemp S, van Kuilenburg ABP (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370:737\u2013749. https:\/\/doi.org\/10.1042\/BJ20021321","journal-title":"Biochem J"},{"key":"1297_CR37","doi-asserted-by":"publisher","first-page":"H252","DOI":"10.1152\/ajpheart.00149.2014","volume":"307","author":"KM Demos-Davies","year":"2014","unstructured":"Demos-Davies KM, Ferguson BS, Cavasin MA, Mahaffey JH, Williams SM, Spiltoir JI, Schuetze KB, Horn TR, Chen B, Ferrara C, Scellini B, Piroddi N, Tesi C, Poggesi C, Jeong MY, McKinsey TA (2014) HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling. Am J Physiol Heart Circ Physiol 307:H252-258. https:\/\/doi.org\/10.1152\/ajpheart.00149.2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1297_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/pds.3651","volume":"23","author":"A Dregan","year":"2014","unstructured":"Dregan A, Charlton J, Wolfe CDA, Gulliford MC, Markus HS (2014) Is sodium valproate, an hdac inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study. Pharmacoepidemiol Drug Saf 23:759\u2013767. https:\/\/doi.org\/10.1002\/pds.3651","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1297_CR39","doi-asserted-by":"publisher","first-page":"C270","DOI":"10.1152\/ajpcell.00194.2015","volume":"310","author":"J Du","year":"2016","unstructured":"Du J, Zhang L, Wang Z, Yano N, Zhao YT, Wei L, Dubielecka-Szczerba P, Liu PY, Zhuang S, Qin G, Zhao TC (2016) Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts. Am J Physiol Cell Physiol 310:C270\u2013C283. https:\/\/doi.org\/10.1152\/ajpcell.00194.2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"1297_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI8768","volume":"106","author":"A Ducharme","year":"2000","unstructured":"Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55\u201362. https:\/\/doi.org\/10.1172\/JCI8768","journal-title":"J Clin Invest"},{"key":"1297_CR41","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1073\/pnas.220413597","volume":"97","author":"X Fang","year":"2000","unstructured":"Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, Mills GB (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97:11960\u201311965. https:\/\/doi.org\/10.1073\/pnas.220413597","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR42","doi-asserted-by":"publisher","first-page":"9806","DOI":"10.1073\/pnas.1301509110","volume":"110","author":"BS Ferguson","year":"2013","unstructured":"Ferguson BS, Harrison BC, Jeong MY, Reid BG, Wempe MF, Wagner FF, Holson EB, McKinsey TA (2013) Signal-dependent repression of DUSP5 by Class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 110:9806\u20139811. https:\/\/doi.org\/10.1073\/pnas.1301509110","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR43","doi-asserted-by":"publisher","first-page":"0123341","DOI":"10.1371\/journal.pone.0123341","volume":"10","author":"DO Frank","year":"2015","unstructured":"Frank DO, Dengjel J, Wilfling F, Kozjak-Pavlovic V, H\u00e4cker G, Weber A (2015) The pro-apoptotic BH3-only protein Bim interacts with components of the translocase of the outer mitochondrial membrane (TOM). PLoS One 10:0123341. https:\/\/doi.org\/10.1371\/journal.pone.0123341","journal-title":"PLoS One"},{"key":"1297_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40360-019-0294-x","volume":"20","author":"JK Freundt","year":"2019","unstructured":"Freundt JK, Frommeyer G, Spieker T, W\u00f6tzel F, Grotthoff JS, Stypmann J, Hempel G, Sch\u00e4fers M, Jacobs AH, Eckardt L, Lange PS (2019) Histone deacetylase inhibition by entinostat for the prevention of electrical and structural remodeling in heart failure. BMC Pharmacol Toxicol 20:16. https:\/\/doi.org\/10.1186\/s40360-019-0294-x","journal-title":"BMC Pharmacol Toxicol"},{"key":"1297_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/cvr\/cvn215","volume":"80","author":"P Gallo","year":"2008","unstructured":"Gallo P, Latronico MVG, Gallo P, Grimaldi S, Borgia F, Todaro M, Jones P, Gallinari P, Francesco RD, Ciliberto G, Steink\u00fchler C, Esposito G, Condorelli G (2008) Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc Res 80:416\u2013424. https:\/\/doi.org\/10.1093\/cvr\/cvn215","journal-title":"Cardiovasc Res"},{"key":"1297_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.gene.2017.02.025","volume":"611","author":"AM Ghaleb","year":"2017","unstructured":"Ghaleb AM, Yang VW (2017) Kr\u00fcppel-like factor 4 (KLF4): what we currently know. Gene 611:27\u201337. https:\/\/doi.org\/10.1016\/j.gene.2017.02.025","journal-title":"Gene"},{"key":"1297_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","volume":"389","author":"M Grunstein","year":"1997","unstructured":"Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389:349\u2013352. https:\/\/doi.org\/10.1038\/38664","journal-title":"Nature"},{"key":"1297_CR48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3892\/ijmm.2017.3101","volume":"40","author":"Y Guo","year":"2017","unstructured":"Guo Y, Li Z, Shi C, Li J, Yao M, Chen X (2017) Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway. Int J Mol Med 40:999\u20131008. https:\/\/doi.org\/10.3892\/ijmm.2017.3101","journal-title":"Int J Mol Med"},{"issue":"11","key":"1297_CR49","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1161\/01.cir.99.11.1508","volume":"99","author":"A Hagendorff","year":"1999","unstructured":"Hagendorff A, Schumacher B, Kirchhoff S, L\u00fcderitz B, Willecke K (1999) Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 99(11):1508\u20131515. https:\/\/doi.org\/10.1161\/01.cir.99.11.1508","journal-title":"Circulation"},{"issue":"Pt 5","key":"1297_CR50","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1242\/jcs.092098","volume":"125","author":"J Hagenbuchner","year":"2012","unstructured":"Hagenbuchner J, Kuznetsov A, Hermann M, Hausott B, Obexer P, Ausserlechner MJ (2012) FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci 125(Pt 5):1191\u20131203. https:\/\/doi.org\/10.1242\/jcs.092098","journal-title":"J Cell Sci"},{"key":"1297_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/371257a0","volume":"371","author":"GJ Hannon","year":"1994","unstructured":"Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257\u2013261. https:\/\/doi.org\/10.1038\/371257a0","journal-title":"Nature"},{"key":"1297_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","volume":"79","author":"M Harada","year":"2015","unstructured":"Harada M, Wagoner DRV, Nattel S (2015) Role of inflammation in atrial fibrillation pathophysiology and management. Circ J 79:495\u2013502. https:\/\/doi.org\/10.1253\/circj.CJ-15-0138","journal-title":"Circ J"},{"key":"1297_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cr.2018.11.002","volume":"8","author":"S Hashmi","year":"2019","unstructured":"Hashmi S, Ahmad HR (2019) Molecular switch model for cardiomyocyte proliferation. Cell Regen 8:12\u201320. https:\/\/doi.org\/10.1016\/j.cr.2018.11.002","journal-title":"Cell Regen"},{"key":"1297_CR54","doi-asserted-by":"publisher","first-page":"H1229","DOI":"10.1152\/ajpheart.00207.2003","volume":"285","author":"S Hayashidani","year":"2003","unstructured":"Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T, Takeshita A (2003) Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285:H1229-1235. https:\/\/doi.org\/10.1152\/ajpheart.00207.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1297_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","volume":"15","author":"M Hedayat","year":"2010","unstructured":"Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N (2010) Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15:543\u2013562. https:\/\/doi.org\/10.1007\/s10741-010-9168-4","journal-title":"Heart Fail Rev"},{"key":"1297_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.yjmcc.2017.12.004","volume":"114","author":"DJ Herr","year":"2018","unstructured":"Herr DJ, Baarine M, Aune SE, Li X, Ball LE, Lemasters JJ, Beeson CC, Chou JC, Menick DR (2018) HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury. J Mol Cell Cardiol 114:309\u2013319. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.12.004","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12192-017-0799-4","volume":"22","author":"X Hu","year":"2017","unstructured":"Hu X, van Marion DMS, Wiersma M, Zhang D, Brundel BJJM (2017) The protective role of small heat shock proteins in cardiac diseases: key role in atrial fibrillation. Cell Stress Chaperones 22:665\u2013674. https:\/\/doi.org\/10.1007\/s12192-017-0799-4","journal-title":"Cell Stress Chaperones"},{"key":"1297_CR58","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1476-5381.2010.00637","volume":"159","author":"A Iyer","year":"2010","unstructured":"Iyer A, Fenning A, Lim J, Le GT, Reid RC, Halili MA, Fairlie DP, Brown L (2010) Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. Br J Pharmacol 159:1408\u20131417. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00637","journal-title":"Br J Pharmacol"},{"key":"1297_CR59","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/1479-7364-4-5-345","volume":"4","author":"BC Jackson","year":"2010","unstructured":"Jackson BC, Carpenter C, Nebert DW, Vasilis Vasiliou V (2010) Update of human and mouse forkhead box (FOX) gene families. Hum Genomics 4:345\u2013352. https:\/\/doi.org\/10.1186\/1479-7364-4-5-345","journal-title":"Hum Genomics"},{"key":"1297_CR60","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s42255-019-0138-4","volume":"1","author":"ZH Jebessa","year":"2019","unstructured":"Jebessa ZH, Shanmukha KD, Dewenter M, Lehmann LH, Xu C, Schreiter F, Siede D, Gong XM, Worst BC, Federico G, Sauer SW, Fischer T, Wechselberger L, M\u00fcller OJ, Sossalla S, Dieterich C, Most P, Gr\u00f6ne HJ, Moro C, Oberer M, Haemmerle G, Katus HA, Tyedmers J, Backs J (2019) The lipid droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4. Nat Metab 1:1157\u20131167. https:\/\/doi.org\/10.1038\/s42255-019-0138-4","journal-title":"Nat Metab"},{"key":"1297_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao0144*","author":"MY Jeong","year":"2018","unstructured":"Jeong MY, Lin YH, Wennersten SA, Demos-Davies KM, Cavasin MA, Mahaffey JH, Monzani V, Saripalli C, Mascagni P, Reece TB, Ambardekar AV, Granzier HL, Dinarello CA, McKinsey TA (2018) Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aao0144*","journal-title":"Sci Transl Med"},{"key":"1297_CR62","doi-asserted-by":"publisher","first-page":"727","DOI":"10.33549\/physiolres.934110","volume":"68","author":"H Jung","year":"2019","unstructured":"Jung H, Lee E, Kim I, Song JH, Kim GJ (2019) Histone deacetylase inhibition has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy. Physiol Res 68:727\u2013737","journal-title":"Physiol Res"},{"key":"1297_CR63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1124\/mol.114.096974","volume":"87","author":"SH Kang","year":"2015","unstructured":"Kang SH, Seok YM, Song MJ, Lee HA, Kurz T, Kim IK (2015) Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats. Mol Pharmacol 87:782\u2013791. https:\/\/doi.org\/10.1124\/mol.114.096974","journal-title":"Mol Pharmacol"},{"key":"1297_CR64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/157340310793566055","volume":"6","author":"G Kapakos","year":"2010","unstructured":"Kapakos G, Bouallegue A, Daou GB, Srivastava AK (2010) Modulatory role of nitric oxide\/cGMP system in endothelin-1-induced signaling responses in vascular smooth muscle cells. Curr Cardiol Rev 6:247\u2013254. https:\/\/doi.org\/10.2174\/157340310793566055","journal-title":"Curr Cardiol Rev"},{"key":"1297_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","volume":"42","author":"A Karimian","year":"2016","unstructured":"Karimian A, Ahmadi Y, Yousefi B (2016) Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst) 42:63\u201371. https:\/\/doi.org\/10.1016\/j.dnarep.2016.04.008","journal-title":"DNA Repair (Amst)"},{"key":"1297_CR66","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.mam.2006.08.007","volume":"27","author":"S Kaushik","year":"2006","unstructured":"Kaushik S, Cuervo AM (2006) Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress. Mol Aspects Med 27:444\u2013454. https:\/\/doi.org\/10.1016\/j.mam.2006.08.007","journal-title":"Mol Aspects Med"},{"key":"1297_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","volume":"113","author":"HJ Kee","year":"2006","unstructured":"Kee HJ, Sohn IS, Nam KI, Park JE, Qian YR, Yin Z, Ahn Y, Jeong MH, Bang YJ, Kim N, Kim JK, Kim KK, Epstein JA, Kook H (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113:51\u201359. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.559724","journal-title":"Circulation"},{"key":"1297_CR68","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.yjmcc.2009.08.022","volume":"47","author":"HJ Kee","year":"2009","unstructured":"Kee HJ, Kook H (2009) Kr\u00fcppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. J Mol Cell Cardiol 47:770\u2013780. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.08.022","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR69","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000350148","volume":"37","author":"HJ Kee","year":"2013","unstructured":"Kee HJ, Bae EH, Park S, Lee KE, Suh SH, Kim SW, Jeong MH (2013) HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCA-salt hypertensive rats via regulation of HDAC6\/HDAC8 enzyme activity. Kidney Blood Press Res 37:229\u2013239. https:\/\/doi.org\/10.1159\/000350148","journal-title":"Kidney Blood Press Res"},{"key":"1297_CR70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nm.3040","volume":"19","author":"J Kim","year":"2013","unstructured":"Kim J, Yujung Kang Y, Kojima Y, Lighthouse JK, Hu X, Aldred MA, McLean DL, Park H, Comhair SA, Greif DM, Erzurum SC, Chun HJ (2013) An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med 19:74\u201382. https:\/\/doi.org\/10.1038\/nm.3040","journal-title":"Nat Med"},{"key":"1297_CR71","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/CIRCULATIONAHA.114.013339","volume":"131","author":"J Kim","year":"2015","unstructured":"Kim J, Hwangbo C, Hu X, Kang Y, Papangeli I, Mehrotra D, Park H, Ju H, McLean DL, Comhair SA, Erzurum SC, Chun HJ (2015) Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension. Circulation 131:190\u2013199. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013339","journal-title":"Circulation"},{"key":"1297_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yjmcc.2018.04.011","volume":"119","author":"D Kimbrough","year":"2018","unstructured":"Kimbrough D, Wang SH, Wright LH, Mani SK, Kasiganesan H, LaRue AC, Cheng Q, Nadig SN, Atkinson C, Menick DR (2018) HDAC inhibition helps post-MI healing by modulating macrophage polarization. J Mol Cell Cardiol 119:51\u201363. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.04.011","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR73","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","volume":"113","author":"Y Kong","year":"2006","unstructured":"Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113:2579\u20132588. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.625467","journal-title":"Circulation"},{"key":"1297_CR74","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1172\/JCI19137","volume":"112","author":"H Kook","year":"2003","unstructured":"Kook H, Lepore JJ, Gitler AD, Lu MM, Yung WWM, Mackay J, Zhou R, Ferrari V, Gruber P, Epstein JA (2003) Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein hop. J Clin Invest 112:863\u2013871. https:\/\/doi.org\/10.1172\/JCI19137","journal-title":"J Clin Invest"},{"key":"1297_CR75","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrc3539","volume":"13","author":"EWF Lam","year":"2013","unstructured":"Lam EWF, Brosens JJ, Gomes AR, Koo CY (2013) Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer 13:482\u2013495. https:\/\/doi.org\/10.1038\/nrc3539","journal-title":"Nat Rev Cancer"},{"key":"1297_CR76","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1101\/gad.9.6.639","volume":"9","author":"MH Lee","year":"1995","unstructured":"Lee MH, Reynisd\u00f3ttir I, Massagu\u00e9 J (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639\u2013649. https:\/\/doi.org\/10.1101\/gad.9.6.639","journal-title":"Genes Dev"},{"key":"1297_CR77","doi-asserted-by":"publisher","first-page":"H968","DOI":"10.1152\/ajpheart.00891.2006","volume":"293","author":"TM Lee","year":"2007","unstructured":"Lee TM, Lin MS, Chang NC (2007) Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am J Physiol Heart Circ Physiol 293:H968-977. https:\/\/doi.org\/10.1152\/ajpheart.00891.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1297_CR78","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3892\/mmr.2017.7905","volume":"17","author":"TI Lee","year":"2018","unstructured":"Lee TI, Bai KJ, Chen YC, Lee TW, Chung CC, Tsai WC, Tsao SY, Kao YH (2018) Histone deacetylase inhibition of cardiac autophagy in rats on a high-fat diet with low-dose streptozotocin-induced type 2 diabetes mellitus. Mol Med Rep 17:594\u2013601. https:\/\/doi.org\/10.3892\/mmr.2017.7905","journal-title":"Mol Med Rep"},{"key":"1297_CR79","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cell.2006.03.046","volume":"125","author":"MK Lehtinen","year":"2006","unstructured":"Lehtinen MK, Yuan Z, Boag PR, Yang Y, Vill\u00e9n J, Becker EBE, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK, Bonni A (2006) A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125:987\u20131001. https:\/\/doi.org\/10.1016\/j.cell.2006.03.046","journal-title":"Cell"},{"key":"1297_CR80","doi-asserted-by":"publisher","first-page":"9494052","DOI":"10.1155\/2018\/9494052","volume":"2018","author":"Y Leng","year":"2018","unstructured":"Leng Y, Wu Y, Lei S, Zhou B, Qiu Z, Wang K, Xia Z (2018) Inhibition of HDAC6 activity alleviates myocardial ischemia\/reperfusion injury in diabetic rats: potential role of peroxiredoxin 1 acetylation and redox regulation. Oxid Med Cell Longev 2018:9494052. https:\/\/doi.org\/10.1155\/2018\/9494052","journal-title":"Oxid Med Cell Longev"},{"key":"1297_CR81","doi-asserted-by":"publisher","first-page":"160177","DOI":"10.1098\/rsob.160177","volume":"6","author":"S Li","year":"2016","unstructured":"Li S, Liu C, Gu L, Wang L, Shang Y, Liu Q, Wan J, Shi J, Wang F, Xu Z, Ji G, Li W (2016) Autophagy protects cardiomyocytes from the myocardial ischaemia-reperfusion injury through the clearance of CLP36. Open Biol 6:160177. https:\/\/doi.org\/10.1098\/rsob.160177","journal-title":"Open Biol"},{"key":"1297_CR82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000449467","volume":"99","author":"RF Li","year":"2017","unstructured":"Li RF, Cao SS, Fang WJ, Song Y, Luo XT, Wang HY, Wang JG (2017) Roles of HDAC2 and HDAC8 in cardiac remodeling in renovascular hypertensive rats and the effects of valproic acid sodium. Pharmacology 99:27\u201339. https:\/\/doi.org\/10.1159\/000449467","journal-title":"Pharmacology"},{"key":"1297_CR83","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI7362","volume":"104","author":"F Liang","year":"1999","unstructured":"Liang F, Gardner DG (1999) Mechanical strain activates BNP gene transcription through a p38\/NF-kappaB-dependent mechanism. J Clin Invest 104:1603\u20131612. https:\/\/doi.org\/10.1172\/JCI7362","journal-title":"J Clin Invest"},{"key":"1297_CR84","doi-asserted-by":"publisher","first-page":"7460","DOI":"10.1128\/MCB.21.21.7460-7469.2001","volume":"21","author":"Q Liang","year":"2001","unstructured":"Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, Molkentin JD (2001) The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 21:7460\u20137469. https:\/\/doi.org\/10.1128\/MCB.21.21.7460-7469.2001","journal-title":"Mol Cell Biol"},{"key":"1297_CR85","doi-asserted-by":"publisher","first-page":"12283","DOI":"10.1073\/pnas.211086598","volume":"98","author":"P Liao","year":"2001","unstructured":"Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, Saffitz J, Chien K, Xiao RP, Kass DA, Wang Y (2001) The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci U S A 98:12283\u201312288. https:\/\/doi.org\/10.1073\/pnas.211086598","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1297_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40360-020-0400-0","volume":"21","author":"CF Lin","year":"2020","unstructured":"Lin CF, Hsu KC, HuangFu WC, Lin TE, Huang HL, Pan SL (2020) Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury. BMC Pharmacol Toxicol 21:21. https:\/\/doi.org\/10.1186\/s40360-020-0400-0","journal-title":"BMC Pharmacol Toxicol"},{"key":"1297_CR87","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling H, Fabbri M, Calin GA (2013) MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12:847\u2013865. https:\/\/doi.org\/10.1038\/nrd4140","journal-title":"Nat Rev Drug Discov"},{"key":"1297_CR88","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.bbamcr.2014.08.002","volume":"1843","author":"L Lipskaia","year":"2014","unstructured":"Lipskaia L, Keuylian Z, Blirando K, Mougenot N, Jacquet A, Rouxel C, Sghairi H, Elaib Z, Blaise R, Adnot S, Hajjar RJ, Chemaly ER, Limon I, Bobe R (2014) Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis. Biochim Biophys Acta 1843:2705\u20132718. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.08.002","journal-title":"Biochim Biophys Acta"},{"key":"1297_CR89","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.yjmcc.2008.08.015","volume":"45","author":"F Liu","year":"2008","unstructured":"Liu F, Levin MD, Petrenko NB, Lu MM, Wang T, Yuan LJ, Stout AL, Epstein JA, Patel VV (2008) Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol 45:715\u2013723. https:\/\/doi.org\/10.1016\/j.yjmcc.2008.08.015","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR90","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000438864","volume":"96","author":"B Lkhagva","year":"2015","unstructured":"Lkhagva B, Lin YK, Kao YH, Chazo TF, Chung CC, Chen SA, Yi-Jen Chen YJ (2015) Novel histone deacetylase inhibitor modulates cardiac peroxisome proliferator-activated receptors and inflammatory cytokines in heart failure. Pharmacology 96:184\u2013191. https:\/\/doi.org\/10.1159\/000438864","journal-title":"Pharmacology"},{"key":"1297_CR91","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1073\/pnas.080064097","volume":"97","author":"J Lu","year":"2000","unstructured":"Lu J, McKinsey TA, Nicol RL, Olson EN (2000) Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 97:4070\u20134075. https:\/\/doi.org\/10.1073\/pnas.080064097","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR92","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1152\/physiolgenomics.00048","volume":"43","author":"G Majumdar","year":"2011","unstructured":"Majumdar G, Rooney RJ, Johnson IM, Raghow R (2011) Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy. Physiol Genomics 43:1319\u20131333. https:\/\/doi.org\/10.1152\/physiolgenomics.00048","journal-title":"Physiol Genomics"},{"key":"1297_CR93","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/1471-2164-13-709","volume":"13","author":"G Majumdar","year":"2012","unstructured":"Majumdar G, Adris P, Bhargava N, Chen H, Raghow R (2012) Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells. BMC Genomics 13:709. https:\/\/doi.org\/10.1186\/1471-2164-13-709","journal-title":"BMC Genomics"},{"key":"1297_CR94","doi-asserted-by":"publisher","first-page":"H1391","DOI":"10.1152\/ajpheart.00390.2014","volume":"308","author":"SK Mani","year":"2015","unstructured":"Mani SK, Kern CB, Kimbrough D, Addy B, Kasiganesan H, Rivers WT, Patel RK, Chou JC, Spinale FG, Mukherjee R, Menick DR (2015) Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction. Am J Physiol Heart Circ Physiol 308:H1391-1401. https:\/\/doi.org\/10.1152\/ajpheart.00390.2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1297_CR95","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/cvr\/cvu122","volume":"103","author":"P Mathiyalagan","year":"2014","unstructured":"Mathiyalagan P, Keating ST, Du X-J, Assam El-Osta A (2014) Chromatin modifications remodel cardiac gene expression. Cardiovasc Res 103:7\u201316. https:\/\/doi.org\/10.1093\/cvr\/cvu122","journal-title":"Cardiovasc Res"},{"key":"1297_CR96","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1161\/hy02t2.102808","volume":"39","author":"M Mendez","year":"2002","unstructured":"Mendez M, LaPointe MC (2002) Trophic effects of the cyclooxygenase-2 product prostaglandin E(2) in cardiac myocytes. Hypertension 39:382\u2013388. https:\/\/doi.org\/10.1161\/hy02t2.102808","journal-title":"Hypertension"},{"key":"1297_CR97","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/ijms19020419","volume":"19","author":"V Meraviglia","year":"2018","unstructured":"Meraviglia V, Bocchi L, Sacchetto R, Florio MC, Motta BM, Corti C, Weichenberger CX, Savi M, D\u2019Elia Y, Rosato-Siri MD, Suffredini S, Piubelli C, Pompilio G, Pramstaller PP, Domingues FS, Stilli D, Rossini A (2018) HDAC inhibition improves the sarcoendoplasmic reticulum Ca 2+-ATPase activity in cardiac myocytes. Int J Mol Sci 19:419. https:\/\/doi.org\/10.3390\/ijms19020419","journal-title":"Int J Mol Sci"},{"key":"1297_CR98","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/labinvest.2010.104","volume":"90","author":"JM Miano","year":"2010","unstructured":"Miano JM (2010) Role of serum response factor in the pathogenesis of disease. Lab Invest 90:1274\u20131284. https:\/\/doi.org\/10.1038\/labinvest.2010.104","journal-title":"Lab Invest"},{"key":"1297_CR99","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41419-017-0174-5","volume":"9","author":"M Milan","year":"2018","unstructured":"Milan M, Pace V, Maiullari F, Chiriv\u00ec M, Baci D, Maiullari S, Madaro L, Maccari S, Stati T, Marano G, Frati G, Puri PL, Falco ED, Bearzi C, Rizzi R (2018) Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation. Cell Death Dis 9:108. https:\/\/doi.org\/10.1038\/s41419-017-0174-5","journal-title":"Cell Death Dis"},{"key":"1297_CR100","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/FJC.0b013e318145ae2e","volume":"50","author":"S Miyatake","year":"2007","unstructured":"Miyatake S, Manabe-Kawaguchi H, Watanabe K, Hori S, Aikawa N, Fukuda K (2007) Prostaglandin E2 induces hypertrophic changes and suppresses alpha-skeletal actin gene expression in rat cardiomyocytes. J Cardiovasc Pharmacol 50:548\u2013554. https:\/\/doi.org\/10.1097\/FJC.0b013e318145ae2e","journal-title":"J Cardiovasc Pharmacol"},{"key":"1297_CR101","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1172\/JCI35847","volume":"118","author":"RL Montgomery","year":"2008","unstructured":"Montgomery RL, Potthoff MJ, Haberland M, Qi X, Matsuzaki S, Humphries KM, Richardson JA, Bassel-Duby R, Olson EN (2008) Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J Clin Invest 118:3588\u20133597. https:\/\/doi.org\/10.1172\/JCI35847","journal-title":"J Clin Invest"},{"key":"1297_CR102","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","volume":"93","author":"A Mosterd","year":"2007","unstructured":"Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93:1137\u20131146. https:\/\/doi.org\/10.1136\/hrt.2003.025270","journal-title":"Heart"},{"key":"1297_CR103","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1248\/bpb.b18-00785","volume":"42","author":"S Nagata","year":"2019","unstructured":"Nagata S, Marunouchi T, Tanonaka K (2019) Histone deacetylase inhibitor SAHA treatment prevents the development of heart failure after myocardial infarction via an induction of heat-shock proteins in rats. Biol Pharm Bull 42:453\u2013461. https:\/\/doi.org\/10.1248\/bpb.b18-00785","journal-title":"Biol Pharm Bull"},{"key":"1297_CR104","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1755-1536-7-10","volume":"7","author":"HF Nural-Guvener","year":"2014","unstructured":"Nural-Guvener HF, Luidmila Zakharova L, Nimlos J, Popovic S, Mastroeni D, Gaballa MA (2014) HDAC class I inhibitor, mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation. Fibrogenesis Tissue Repair 7:10. https:\/\/doi.org\/10.1186\/1755-1536-7-10","journal-title":"Fibrogenesis Tissue Repair"},{"key":"1297_CR105","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.3390\/ijms160511482","volume":"16","author":"H Nural-Guvener","year":"2015","unstructured":"Nural-Guvener H, Zakharova L, Feehery L, Sljukic S, Gaballa M (2015) Anti-fibrotic effects of class I HDAC inhibitor, mocetinostat is associated with IL-6\/Stat3 signaling in ischemic heart failure. Int J Mol Sci 16:11482\u201311499. https:\/\/doi.org\/10.3390\/ijms160511482","journal-title":"Int J Mol Sci"},{"key":"1297_CR106","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.1074\/jbc.M113.545822","volume":"289","author":"S O'Reilly","year":"2014","unstructured":"O\u2019Reilly S, Ciechomska M, Cant R, van Laar JM (2014) Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-\u03b2 (TGF-\u03b2) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem 289:9952\u20139960. https:\/\/doi.org\/10.1074\/jbc.M113.545822","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"1297_CR107","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.2337\/dc08-s247","volume":"31","author":"TM Paravicini","year":"2008","unstructured":"Paravicini TM, Touyz RM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31(Suppl 2):S170-180. https:\/\/doi.org\/10.2337\/dc08-s247","journal-title":"Diabetes Care"},{"key":"1297_CR108","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1073\/pnas.0803749105","volume":"105","author":"RB Parmigiani","year":"2008","unstructured":"Parmigiani RB, Xu WS, Venta-Perez G, Erdjument-Bromage H, Yaneva M, Tempst P, Marks PA (2008) HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proc Natl Acad Sci USA 105:9633\u20139638. https:\/\/doi.org\/10.1073\/pnas.0803749105","journal-title":"Proc Natl Acad Sci USA"},{"key":"1297_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12012-017-9406-2","volume":"18","author":"BM Patel","year":"2018","unstructured":"Patel BM (2018) Sodium butyrate controls cardiac hypertrophy in experimental models of rats. Cardiovasc Toxicol 18:1\u20138. https:\/\/doi.org\/10.1007\/s12012-017-9406-2","journal-title":"Cardiovasc Toxicol"},{"key":"1297_CR110","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3390\/cells9061535","volume":"9","author":"AS Poltavets","year":"2020","unstructured":"Poltavets AS, Vishnyakova PA, Elchaninov AV, Sukhikh GT, Fatkhudinov TK (2020) Macrophage modification strategies for efficient cell therapy. Cells 9:1535. https:\/\/doi.org\/10.3390\/cells9061535","journal-title":"Cells"},{"key":"1297_CR111","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pharmthera.2011.11.004","volume":"133","author":"K Raedschelders","year":"2012","unstructured":"Raedschelders K, Ansley DM, Chen DDY (2012) The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133:230\u2013255. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.11.004","journal-title":"Pharmacol Ther"},{"key":"1297_CR112","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1139\/cjpp-2016-0542","volume":"95","author":"S Raghunathan","year":"2017","unstructured":"Raghunathan S, Goyal RK, Patel BM (2017) Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy. Can J Physiol Pharmacol 95:260\u2013267. https:\/\/doi.org\/10.1139\/cjpp-2016-0542","journal-title":"Can J Physiol Pharmacol"},{"key":"1297_CR113","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCHEARTFAILURE.114.001781","volume":"8","author":"L Renaud","year":"2015","unstructured":"Renaud L, Harris LG, Mani SK, Kasiganesan H, Chou JC, Baicu CF, Laer AV, Akerman AW, Stroud RE, Jones JA, Zile MR, Menick DR (2015) HDACs regulate miR-133a expression in pressure overload-induced cardiac fibrosis. Circ Heart Fail 8:1094\u20131104. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001781","journal-title":"Circ Heart Fail"},{"key":"1297_CR114","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1177\/2047487317715769","volume":"24","author":"V Ruddox","year":"2017","unstructured":"Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE (2017) Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol 24:1555\u20131566. https:\/\/doi.org\/10.1177\/2047487317715769","journal-title":"Eur J Prev Cardiol"},{"key":"1297_CR115","doi-asserted-by":"publisher","first-page":"e0213186","DOI":"10.1371\/journal.pone.0213186","volume":"14","author":"Y Ryu","year":"2019","unstructured":"Ryu Y, Kee HJ, Sun S, Seok YM, Choi SY, Kim GR, Kee SJ, Pflieger M, Kurz T, Kim HS, Jeong MH (2019) Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension. PLoS ONE 14:e0213186. https:\/\/doi.org\/10.1371\/journal.pone.0213186","journal-title":"PLoS ONE"},{"key":"1297_CR116","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15096.1","author":"M Saleh","year":"2018","unstructured":"Saleh M, Ambrose JA (2018) Understanding myocardial infarction. F1000Res 7:F1000 Faculty Rev. https:\/\/doi.org\/10.12688\/f1000research.15096.1","journal-title":"F1000Res 7:F1000 Faculty Rev"},{"key":"1297_CR117","doi-asserted-by":"publisher","first-page":"75","DOI":"10.12659\/MSMBR.900437","volume":"22","author":"M Samak","year":"2016","unstructured":"Samak M, Fatullayev J, Sabashnikov A, Zeriouh M, Schmack B, Farag M, Popov A-F, Dohmen PM, Choi YH, Wahlers T, Weymann A (2016) Cardiac hypertrophy: an introduction to molecular and cellular basis. Med Sci Monit Basic Res 22:75\u201379","journal-title":"Med Sci Monit Basic Res"},{"key":"1297_CR118","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.acvd.2016.03.004","volume":"109","author":"D Santos-Ribeiro","year":"2016","unstructured":"Santos-Ribeiro D, Mendes-Ferreira P, Maia-Rocha C, Ad\u00e3o R, Leite-Moreira AF, Br\u00e1s-Silva C (2016) Pulmonary arterial hypertension: basic knowledge for clinicians. Arch Cardiovasc Dis 109:550\u2013561. https:\/\/doi.org\/10.1016\/j.acvd.2016.03.004","journal-title":"Arch Cardiovasc Dis"},{"key":"1297_CR119","doi-asserted-by":"publisher","first-page":"e007071","DOI":"10.1161\/CIRCEP.118.007071","volume":"12","author":"B Scholz","year":"2019","unstructured":"Scholz B, Schulte JS, Hamer S, Himmler K, Pluteanu F, Seidl MD, Stein J, Wardelmann E, Hammer EH, V\u00f6lker U, M\u00fcller FU (2019) HDAC (histone deacetylase) inhibitor valproic acid attenuates atrial remodeling and delays the onset of atrial fibrillation in mice. Circ Arrhythm Electrophysiol 12:e007071. https:\/\/doi.org\/10.1161\/CIRCEP.118.007071","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1297_CR120","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1006\/jmcc.1999.0981","volume":"31","author":"U Schotten","year":"1999","unstructured":"Schotten U, Koenigs B, Rueppel M, Schoendube F, Boknik P, Schmitz W, Hanrath P (1999) Reduced myocardial sarcoplasmic reticulum Ca2+-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy. J Mol Cell Cardiol 31:1483\u20131494. https:\/\/doi.org\/10.1006\/jmcc.1999.0981","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR122","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1124\/jpet.116.234591","volume":"358","author":"M Seki","year":"2016","unstructured":"Seki M, LaCanna R, Powers JC, Vrakas C, Liu F, Berretta R, Chacko G, Holten J, Jadiya P, Wang T, Arkles JS, Copper JM, Houser SR, Huang J, Patel VV, Recchia FA (2016) Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation. J Pharmacol Exp Ther 358:441\u2013449. https:\/\/doi.org\/10.1124\/jpet.116.234591","journal-title":"J Pharmacol Exp Ther"},{"key":"1297_CR123","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/s0092-8674(02)00933-9","volume":"110","author":"CH Shin","year":"2002","unstructured":"Shin CH, Liu ZP, Passier R, Zhang CL, Wang DZ, Harris TM, Yamagishi H, Richardson JA, Childs G, Olson EN (2002) Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110:725\u2013735. https:\/\/doi.org\/10.1016\/s0092-8674(02)00933-9","journal-title":"Cell"},{"key":"1297_CR124","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1586\/era.10.62","volume":"10","author":"BN Singh","year":"2010","unstructured":"Singh BN, Zhang G, Hwa YL, Li J, Dowdy SC, Jiang SW (2010) Nonhistone protein acetylation as cancer therapy targets. Expert Rev Anticancer Ther 10:935\u2013954. https:\/\/doi.org\/10.1586\/era.10.62","journal-title":"Expert Rev Anticancer Ther"},{"key":"1297_CR125","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yjmcc.2018.10.007","volume":"124","author":"R Song","year":"2018","unstructured":"Song R, Yang Y, Lei H, Wang G, Huang Y, Xue W, Wang Y, Yao L, Zhu Y (2018) HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving \u03b1-tubulin acetylation. J Mol Cell Cardiol 124:58\u201369. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.007","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR126","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/excr.2001.5447","volume":"274","author":"N Takeyama","year":"2002","unstructured":"Takeyama N, Miki S, Hirakawa A, Tanaka T (2002) Role of the mitochondrial permeability transition and cytochrome c release in hydrogen peroxide-induced apoptosis. Exp Cell Res 274:16\u201324. https:\/\/doi.org\/10.1006\/excr.2001.5447","journal-title":"Exp Cell Res"},{"key":"1297_CR127","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","volume":"365","author":"V Talman","year":"2016","unstructured":"Talman V, Ruskoaho H (2016) Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res 365:563\u2013581. https:\/\/doi.org\/10.1007\/s00441-016-2431-9","journal-title":"Cell Tissue Res"},{"key":"1297_CR128","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ebiom.2018.12.003","volume":"39","author":"S Tian","year":"2019","unstructured":"Tian S, Lei I, Gao W, Liu L, Guo Y, Creech J, Herron TJ, Xian S, Ma PX, Chen YE, Li Y, Alam HB, Wang Z (2019) HDAC Inhibitor valproic acid protects heart function through foxm1 pathway after acute myocardial infarction. EBioMedicine 39:83\u201394. https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.003","journal-title":"EBioMedicine"},{"key":"1297_CR129","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nm1552","volume":"13","author":"CM Trivedi","year":"2007","unstructured":"Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, Ferrari VA, Abrams CS, Gruber PJ, Epstein JA (2007) Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3\u00df activity. Nat Med 13:324\u2013331. https:\/\/doi.org\/10.1038\/nm1552","journal-title":"Nat Med"},{"key":"1297_CR130","doi-asserted-by":"publisher","first-page":"26484","DOI":"10.1074\/jbc.M803686200","volume":"283","author":"CM Trivedi","year":"2008","unstructured":"Trivedi CM, Lu MM, Wang Q, Epstein JA (2008) Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy. J Biol Chem 283:26484\u201326489. https:\/\/doi.org\/10.1074\/jbc.M803686200","journal-title":"J Biol Chem"},{"key":"1297_CR131","doi-asserted-by":"publisher","first-page":"8374","DOI":"10.1128\/MCB.24.19.8374-8385.2004","volume":"24","author":"RB Vega","year":"2004","unstructured":"Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, McKinsey TA (2004) Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24:8374\u20138385. https:\/\/doi.org\/10.1128\/MCB.24.19.8374-8385.2004","journal-title":"Mol Cell Biol"},{"key":"1297_CR132","doi-asserted-by":"publisher","first-page":"24471","DOI":"10.1074\/jbc.M702697200","volume":"282","author":"SJ Wall","year":"2007","unstructured":"Wall SJ, Zhong ZD, DeClerck YA (2007) The cyclin-dependent kinase inhibitors p15INK4B and p21CIP1 are critical regulators of fibrillar collagen-induced tumor cell cycle arrest. J Biol Chem 282:24471\u201324476. https:\/\/doi.org\/10.1074\/jbc.M702697200","journal-title":"J Biol Chem"},{"key":"1297_CR133","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1126\/scitranslmed.aay7205","volume":"12","author":"M Wallner","year":"2020","unstructured":"Wallner M, Eaton DM, Berretta RM, Liesinger L, Schittmayer M, Gindlhuber J, Wu J, Jeong MY, Lin YH, Borghetti G, Baker ST, Zhao H, Pfleger J, Blass S, Rainer PP, von Lewinski D, Bugger H, Mohsin S, Graier WF, Zirlik A, McKinsey TA, Birner-Gruenberger R, Wolfson MR, Houser SR (2020) HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction. Sci Transl Med 12:7205. https:\/\/doi.org\/10.1126\/scitranslmed.aay7205","journal-title":"Sci Transl Med"},{"key":"1297_CR134","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s0092-8674(01)00404-4","volume":"105","author":"D Wang","year":"2001","unstructured":"Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105:851\u2013862. https:\/\/doi.org\/10.1016\/s0092-8674(01)00404-4","journal-title":"Cell"},{"key":"1297_CR135","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1136\/heartjnl-2018-314267","volume":"105","author":"RS Wijesurendra","year":"2019","unstructured":"Wijesurendra RS, Casadei B (2019) Mechanisms of atrial fibrillation. Heart 105:1860\u20131867. https:\/\/doi.org\/10.1136\/heartjnl-2018-314267","journal-title":"Heart"},{"key":"1297_CR136","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yjmcc.2013.12.013","volume":"67","author":"SM Williams","year":"2014","unstructured":"Williams SM, Golden-Mason L, Ferguson BS, Schuetze KB, Cavasin MA, Demos-Davies K, Yeager ME, Stenmark KR, McKinsey TA (2014) Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. J Mol Cell Cardiol 67:112\u2013125. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.12.013","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR137","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2174\/1566524019666190208102729","volume":"18","author":"AM Williams","year":"2018","unstructured":"Williams AM, He W, Li Y, Bhatti UF, Nikolian VC, Chang P, Chang Z, Halaweish I, Liu B, Cheng X, Alam HB (2018) Histone deacetylase inhibition attenuates cardiomyocyte hypoxia-reoxygenation injury. Curr Mol Med 18:711\u2013718. https:\/\/doi.org\/10.2174\/1566524019666190208102729","journal-title":"Curr Mol Med"},{"key":"1297_CR138","doi-asserted-by":"publisher","first-page":"e95824","DOI":"10.1172\/jci.insight.95824","volume":"3","author":"LH Wright","year":"2018","unstructured":"Wright LH, Herr DJ, Brown SS, Kasiganesan H, Menick DR (2018) Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling. JCI Insight 3:e95824. https:\/\/doi.org\/10.1172\/jci.insight.95824","journal-title":"JCI Insight"},{"key":"1297_CR139","doi-asserted-by":"publisher","first-page":"8208065","DOI":"10.1155\/2017\/8208065","volume":"2017","author":"Y Wu","year":"2017","unstructured":"Wu Y, Leng Y, Meng Q, Xue R, Zhao B, Zhan L, Xia Z (2017) Suppression of excessive histone deacetylases activity in diabetic hearts attenuates myocardial ischemia\/reperfusion injury via mitochondria apoptosis pathway. J Diabetes Res 2017:8208065. https:\/\/doi.org\/10.1155\/2017\/8208065","journal-title":"J Diabetes Res"},{"key":"1297_CR140","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/01.RES.0000218781.23144.3e","volume":"98","author":"W Xing","year":"2006","unstructured":"Xing W, Zhang TC, Cao D, Wang Z, Antos CL, Li S, Wang Y, Olson EN, Wang DZ (2006) Myocardin induces cardiomyocyte hypertrophy. Circ Res 98:1089\u20131097. https:\/\/doi.org\/10.1161\/01.RES.0000218781.23144.3e","journal-title":"Circ Res"},{"key":"1297_CR141","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cmet.2013.06.005","volume":"18","author":"X Xu","year":"2013","unstructured":"Xu X, Duan S, Yi F, Ocampo A, Liu GH, Belmonte JCI (2013) Mitochondrial regulation in pluripotent stem cells. Cell Metab 18:325\u2013332. https:\/\/doi.org\/10.1016\/j.cmet.2013.06.005","journal-title":"Cell Metab"},{"key":"1297_CR142","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1042\/CS20170064","volume":"131","author":"Z Xu","year":"2017","unstructured":"Xu Z, Tong Q, Zhang Z, Wang S, Zheng Y, Liu Q, Qian LB, Chen SY, Sun J, Cai L (2017) Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1\/2 pathway. Clin Sci (Lond) 131:1841\u20131857. https:\/\/doi.org\/10.1042\/CS20170064","journal-title":"Clin Sci (Lond)"},{"key":"1297_CR143","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.vph.2015.04.005","volume":"73","author":"Q Yang","year":"2015","unstructured":"Yang Q, Sun M, Ramchandran R, Raj JU (2015) IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: role of epigenetic regulation. Vascul Pharmacol 73:20\u201331. https:\/\/doi.org\/10.1016\/j.vph.2015.04.005","journal-title":"Vascul Pharmacol"},{"key":"1297_CR144","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yjmcc.2019.03.008","volume":"130","author":"J Yang","year":"2019","unstructured":"Yang J, He J, Ismail M, Tweeten S, Zeng F, Gao L, Ballinger S, Young M, Prabhu SD, Rowe GC, Zhang J, Zhou L, Xie M (2019) HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia\/reperfusion injury. J Mol Cell Cardiol 130:36\u201348. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.03.008","journal-title":"J Mol Cell Cardiol"},{"key":"1297_CR145","doi-asserted-by":"publisher","first-page":"26107","DOI":"10.1074\/jbc.M114.582809","volume":"289","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Yamashita M, Horimai C, Hayashi M (2014) Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity. J Biol Chem 289:26107\u201326118. https:\/\/doi.org\/10.1074\/jbc.M114.582809","journal-title":"J Biol Chem"},{"key":"1297_CR146","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1083\/jcb.139.1.115","volume":"139","author":"D Zechner","year":"1997","unstructured":"Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC (1997) A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 139:115\u2013127. https:\/\/doi.org\/10.1083\/jcb.139.1.115","journal-title":"J Cell Biol"},{"key":"1297_CR147","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1152\/japplphysiol.00006.2018","volume":"125","author":"LX Zhang","year":"1985","unstructured":"Zhang LX, Du J, Zhao YT, Wang J, Zhang S, Dubielecka PM, Wei L, Zhuang S, Qin G, Chin YE, Zhao TC (1985) Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium. J Appl Physiol 125:1968\u20131978. https:\/\/doi.org\/10.1152\/japplphysiol.00006.2018","journal-title":"J Appl Physiol"},{"key":"1297_CR148","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0092-8674(02)00861-9","volume":"110","author":"CL Zhang","year":"2002","unstructured":"Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479\u2013488. https:\/\/doi.org\/10.1016\/s0092-8674(02)00861-9","journal-title":"Cell"},{"key":"1297_CR149","doi-asserted-by":"publisher","first-page":"39338","DOI":"10.1074\/jbc.M112.379115","volume":"287","author":"L Zhang","year":"2012","unstructured":"Zhang L, Chen B, Zhao Y, Dubielecka PM, Wei L, Qin GJ, Chin YE, Wang Y, Zhao TC (2012a) Inhibition of histone deacetylase-induced myocardial repair is mediated by C-Kit in infarcted hearts. J Biol Chem 287:39338\u201339348. https:\/\/doi.org\/10.1074\/jbc.M112.379115","journal-title":"J Biol Chem"},{"key":"1297_CR150","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1124\/jpet.111.189910","volume":"341","author":"L Zhang","year":"2012","unstructured":"Zhang L, Qin X, Zhao Y, Fast L, Zhuang S, Liu P, Cheng G, Zhao TC (2012b) Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J Pharmacol Exp Ther 341:285\u2013293. https:\/\/doi.org\/10.1124\/jpet.111.189910","journal-title":"J Pharmacol Exp Ther"},{"key":"1297_CR151","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.113.005300","volume":"129","author":"D Zhang","year":"2014","unstructured":"Zhang D, Wu CT, Qi XY, Meijering RAM, Hoogstra-Berends F, Tadevosyan A, Deniz GC, Durdu S, Akar AR, Sibon OCM, Nattel S, Henning RH, Brundel BJJM (2014) Activation of histone deacetylase-6 induces contractile dysfunction through derailment of \u03b1-tubulin proteostasis in experimental and human atrial fibrillation. Circulation 129:346\u2013358. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005300","journal-title":"Circulation"},{"key":"1297_CR152","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/jcb.25902","volume":"118","author":"L Zhang","year":"2017","unstructured":"Zhang L, Du J, Yano N, Wang H, Zhao YT, Dubielecka PM, Zhuang S, Chin YE, Qin G, Zhao TC (2017) Sodium butyrate protects-against high fat diet-induced cardiac dysfunction and metabolic disorders in type II diabetic mice. J Cell Biochem 118:2395\u20132408. https:\/\/doi.org\/10.1002\/jcb.25902","journal-title":"J Cell Biochem"},{"key":"1297_CR153","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.1111\/jcmm.14684","volume":"23","author":"L Zhang","year":"2019","unstructured":"Zhang L, Deng M, Lu A, Chen Y, Yang Chen Y, Wu C, Tan Z, Boini KM, Yang T, Zhu Q, Wang L (2019) Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2\/PGE2 pathway via a HDAC5\/HDAC6-dependent mechanism. J Cell Mol Med 23:8139\u20138150. https:\/\/doi.org\/10.1111\/jcmm.14684","journal-title":"J Cell Mol Med"},{"key":"1297_CR154","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/sj.bjp.0707503","volume":"152","author":"M Zhao","year":"2007","unstructured":"Zhao M (2007) PTEN: a promising pharmacological target to enhance epithelial wound healing. Br J Pharmacol 152:1141\u20131144. https:\/\/doi.org\/10.1038\/sj.bjp.0707503","journal-title":"Br J Pharmacol"},{"key":"1297_CR155","doi-asserted-by":"publisher","first-page":"e65474","DOI":"10.1371\/journal.pone.0065474","volume":"8","author":"TC Zhao","year":"2013","unstructured":"Zhao TC, Du J, Zhuang S, Liu P, Zhang LX (2013) HDAC inhibition elicits myocardial protective effect through modulation of MKK3\/Akt-1. PLoS ONE 8:e65474. https:\/\/doi.org\/10.1371\/journal.pone.0065474","journal-title":"PLoS ONE"},{"key":"1297_CR156","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cardiores.2006.02.019","volume":"71","author":"AV Zima","year":"2006","unstructured":"Zima AV, Blatter LA (2006) Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 71:310\u2013321. https:\/\/doi.org\/10.1016\/j.cardiores.2006.02.019","journal-title":"Cardiovasc Res"},{"key":"1297_CR157","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s0092-8674(00)81588-3","volume":"94","author":"J Zou","year":"1998","unstructured":"Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94:471\u2013480. https:\/\/doi.org\/10.1016\/s0092-8674(00)81588-3","journal-title":"Cell"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01297-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-020-01297-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01297-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T01:27:28Z","timestamp":1607045248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-020-01297-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":156,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1007\/s12272-020-01297-0","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"11 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author has no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}